NEW GOODRX REPORT UNDERSCORES NEED FOR CONGRESS TO HOLD BIG PHARMA ACCOUNTABLE
Jul 2, 2024
Latest Data Finds List Prices of Prescription Drug Prices Have Increased… Read More
© 2024 CSRXP- All Rights Reserved
Statements
CSRXP COMMENDS PRESIDENT BIDEN FOR HOLDING BIG PHARMA ACCOUNTABLE FOR PATENT ABUSE AND EGREGIOUS PRICING ON BRAND NAME INHALERS
Apr 3, 2024
President Says ‘Drug Companies Are Charging Exorbitant Prices’ in Press… Read More
CSRXP APPLAUDS FTC CRACKDOWN ON BIG PHARMA’S FLAGRANT ABUSE OF THE PATENT SYSTEM
Nov 7, 2023
Commission Targets More Than 100 Patents on Brand Name Products Listed in the… Read More
CSRXP COMMENDS HELP COMMITTEE FOR ADVANCING BIPARTISAN, MARKET-BASED SOLUTIONS TO HOLD BIG PHARMA ACCOUNTABLE
May 11, 2023
Senate Panel Passes Bills to Increase Competition and Increase List Price… Read More
CSRXP COMMENDS ADVANCEMENT OF BILL TO BOOST AGENCY COOPERATION TO CRACK DOWN ON BIG PHARMA’S PATENT ABUSE
Jul 28, 2022
Bipartisan Interagency Patent Coordination and Improvement Act of 2022 Will… Read More
CSRXP COMMENDS PRESIDENT BIDEN FOR RENEWING COMMITMENT TO LOWERING DRUG PRICES, CONGRESS MUST ACT
Mar 2, 2022
Lawmakers Must Deliver on Repeated Promises to Hold Big Pharma Accountable… Read More
CSRXP STATEMENT ON PROPOSED CMS COVERAGE DECISION FOR ADUHELM
Jan 12, 2022
DECISION WILL HELP PROTECT SENIORS, TAXPAYERS AND THE U.S. HEALTH SYSTEM FROM… Read More
CSRXP STATEMENT ON U.S. SENATE PASSAGE OF REBATE RULE DELAY & REFUND ACT AS PART OF BIPARTISAN INFRASTRUCTURE BILL
Aug 10, 2021
Lawmakers Must Build on Momentum For Action With Permanent Repeal of Rebate… Read More
CSRxP COMMENDS PRESIDENT BIDEN FOR RENEWED COMMITMENT TO HOLDING BIG PHARMA ACCOUNTABLE
Jul 9, 2021
Campaign Looks Forward to Working with Administration and Congress to Crack… Read More
CSRXP COMMENDS PRESIDENT BIDEN FOR RENEWING COMMITMENT TO LOWERING PRESCRIPTION DRUG PRICES IN BUDGET
May 28, 2021
Time for the Administration and Congress to Convert Promises Made Into… Read More
CSRXP WELCOMES U.S. SENATE HEARING ON OUT-OF-CONTROL PRESCRIPTION DRUG PRICES
Mar 22, 2021
Lawmakers on HELP Subcommittee Can Add to Bipartisan Momentum to Hold Big… Read More
CSRXP COMMENDS LAWMAKERS FOR REFOCUSING CRITICAL ATTENTION ON BIG PHARMA’S EGREGIOUS PRICE HIKES AND PRACTICES
Sep 30, 2020
House Committee on Oversight and Reform to Question Big Pharma Executives… Read More